<div><div><p>[SINGAPORE] The following companies saw new developments that may affect trading of their securities on Tuesday (Aug 19):</p><p>Yangzijiang Financial: The investment holding company said on Monday that it will be the anchor investor in a S$100 million fund by ICH Asset Management, led by Vincent Toe, the Singapore-listed company’s former chief executive. The fund will focus exclusively on Singapore’s small and medium-sized enterprises and is expected to start investing from September this year. The group did not specify the exact sum it would invest in the fund, though it did state the initial pipeline of opportunities include companies from the sectors of healthcare, technology, sustainability, and consumer-services. Shares of Yangzijiang Financial ended Monday flat at S$1.06 before the news. </p><p>Marco Polo Marine: The integrated marine logistics group on Monday posted a 4 per cent decline in gross profit to S$14 million for its third quarter ended Jun 30, 2025, from S$14.6 million in the year-ago period. Its revenue fell 9 per cent on the year to S$31.7 million, from S$34.9 million previously. Shares of Marco Polo Marine ended Monday unchanged at S$0.065, before the announcement.</p><div><div><div><div id="dfp-ad-imu1"></div></div></div></div><p> (CMS): The pharmaceutical company posted a rise in first half profit and declared an interim dividend on Monday, its first set of results after its secondary listing on the Singapore Exchange. Net profit rose 3.4 per cent to 941.2 million yuan (S$168.3 million) compared to the year ago period, as the negative impact of China’s national volume-based procurement policy declined and sales of the group’s products grew. Shares of CMS closed Monday 0.905 per cent or S$0.02 up at S$2.23.</p><p>Clearbridge Health: The healthcare company said on Monday that it has raised S$1.98 million in a fully-subscribed placement of 990 million shares, at S$0.002 each. This has been backed by Singapore fund manager Azure Capital, family office Asdew Acquisitions and veteran investor Ramesh Chandiramani, on plans to enter a new business through the acquisition of  biopharma company Elpis Biopharmaceuticals  for US$330 million.  The placement has allowed Clearbridge to become debt-free, and the proceeds will be used to fund the planned acquisition and for general working capital. The counter ended Monday flat at S$0.004 before the news. </p></div><div>Stocks to watchSingapore stock marketSingapore Stocks</div><div><section><section><p>Share with us your feedback on BT's products and services</p><div>Feedback</div></section></section></div><div><div><div><div id="dfp-ad-imu1"></div></div></div></div></div>

9RQR

明策集团

<p>在 8 月 19 日，新加坡的几家公司报告了影响其股票的重要进展。扬子江金融将成为一只专注于中小企业的 1 亿新元基金的主要投资者。马可波罗海洋报告第三季度毛利润下降 4%。中国医疗系统宣布上半年利润增长 3.4%，并宣告派发中期股息。明策集团为计划收购 Elpis 生物制药筹集了 198 万新元，并在此过程中实现了无债务状态。在公告发布之前，大多数公司的股票保持稳定</p>

值得关注的股票包括：扬子江金融、马可波罗海运、中国医疗系统以及明策健康